Table-IV.

Comparison of global health status, functional scales and symptom scales before and after intervention in CLA and placebo groups.

	CLA group (n=15)	Placebo group (n=16)	P*
Global Health status
Before	70±14.363	73.71±19.19
After	83.33±10.91	55.12±32.90
**P(Before-After)	<0.001	0.02
¶Change	12.22(5.51-20.12)	-17.36(-0.39- -34.32)	<0.001
Functional Scales
Before	76.75±17.27	83.33±17.17
After	86.15±12.99	72.22±28.24
**P(Before-After)	0.11	0.17
Change¶	9.40(-2.51-21.31)	-11.11(-27.97-5.75)	0.03
Symptom, Scales
§Before	14.52±11.24	14.50±17.71
§After	7.69±11.62	30.96±20.57
§§P(Before-After)	0.14	0.01
¶ Change	-7.49(-17.26-2.27)	15.90(3.29-28.52)	0.001

CLA, conjugated linoleic acid, change (differences of baseline and after intervention),

^*P, comparison between group by independent t-test;

^**P comparison within group by paired t –test;

^§§P comparison within group by Sign test, ANCOVA was used to adjust baseline values of variables;

^¶mean value (95% confidence interval);

^§Mean value±standard deviation.